Edelberg Jay - 17 Jun 2026 Form 4 Insider Report for Kardigan, Inc. (KARD)

Reporting relationship: Chief Medical Officer
Issuer ticker: KARD
Reported as of: 17 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 19:14:26 UTC
Source filing: View source filing
Reporting owner signature: /s/ John B. Moriarty, Jr., Attorney-in-Fact

Key filing fact

Edelberg Jay filed Form 4 for Kardigan, Inc. (KARD) on 22 Jun 2026.

Key facts

This page summarizes Edelberg Jay's Form 4 filing for Kardigan, Inc. (KARD).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Jun 2026, 19:14.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002138489 Primary reporting owner

Edelberg Jay

Relationship: Chief Medical Officer
Address: C/O KARDIGAN, INC., 506 CARNEGIE CENTER DRIVE, SUITE 201, PRINCETON
Signature: /s/ John B. Moriarty, Jr., Attorney-in-Fact
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KARD transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +97,587
Change %: +257%
Price
Shares after: 135,543
Date: 17 Jun 2026
Ownership: Direct
Footnotes: F1

KARD transaction

Common Stock

Award

Transaction value
Shares: +47,784
Change %: +35%
Price: $0.000000^*
Shares after: 183,327
Date: 17 Jun 2026
Ownership: Direct
Footnotes: F2

KARD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,459,840
Date: 17 Jun 2026
Ownership: By Edelberg Family Ventures, LLC
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KARD transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares: -61,268
Change %: -100%
Price
Shares after: 0
Date: 17 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 97,587
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each share of Series B Preferred Stock (the "Preferred Stock") was convertible into Common Stock on a 1.5928 for 1 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 upon the effectiveness of the Issuer's registration statement on Form S-1 relating to its initial public offering on June 17, 2026 and without payment of consideration. The Preferred Stock had no expiration date.

Footnote F2

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on June 17, 2028, subject to the Reporting Person's continuous service as of the applicable vesting date.

Footnote F3

Represents shares held by Edelberg Family Ventures, LLC. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.